Home > Products > Primary Cells > Human Primary Cells > Immune System Primary Cells >
Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) | ||||
|---|---|---|---|---|
| Product Name | Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) | |||
| Price | Get Quote | |||
| Cat.No | ABC-TC3008 | Species | Human | |
| Size/Quantity | 1 vial | Biosafety Level | 1 | |
| Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
| Description | Acute Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from adult Acute Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. Acute Lymphoid Leukemia-PB-CD19+ B cells are available in the newly diagnosed and relapsed/refractory stages. | |||
| Disease | Acute Lymphoid Leukemia | |||
| Source Organ | Peripheral Blood | |||
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. | |||
| Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
| Application | For research use only | |||
| Growth Conditions | 37 ℃, 5% CO2 | |||
| Cell Type | B Cell | |||
| Growth Mode | Suspension | |||
| Product Type | Immune Cells | |||
| Product Image |  | |||
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
